Search results for "methylprednisolone"

showing 10 items of 51 documents

Tacrolimus Monotherapy Without Steroids After Liver Transplantation – A Prospective Randomized Double-Blinded Placebo-Controlled Trial

2007

Early steroid withdrawal after liver transplantation (LT) is desirable in order to reduce steroid side effects. Between February 2000 and August 2004, 110 patients after LT were included in this prospective, randomized, double-blind, placebo-controlled trial. Randomization was performed before LT. In all patients, tacrolimus was used without induction therapy. All patients received methylprednisolon for 14 days, thereafter a double-blinded medication containing either placebo (n = 56) or methylprednisolon (n = 54) for 6 months, which was completely stopped thereafter. End points were patient and graft survival, acute and chronic rejection, and incidence of steroid side effects during the fi…

AdultGraft RejectionMalemedicine.medical_specialtyTime FactorsRandomizationmedicine.drug_classmedicine.medical_treatmentPlacebo-controlled studyLiver transplantationPlaceboMethylprednisoloneGastroenterologyTacrolimuslaw.inventionPlacebosDouble-Blind MethodRandomized controlled trialAdrenal Cortex HormoneslawInternal medicinemedicineHumansImmunology and AllergyPharmacology (medical)Antibacterial agentTransplantationbusiness.industryMiddle AgedTacrolimusLiver TransplantationSurgeryCorticosteroidFemaleSafetybusinessImmunosuppressive AgentsFollow-Up StudiesAmerican Journal of Transplantation
researchProduct

Oral granisetron with or without methylprednisolone versus metoclopramide plus methylprednisolone in the management of delayed nausea and vomiting in…

1995

Background. A single-institution, randomized open trial was prospectively performed to compare orally administered granisetron with or without intramuscularly administered methylprednisolone to metoclopramide plus methylprednisolone in the prevention of delayed nausea and vomiting induced by cisplatin-based chemotherapy. The effects of antiemetic treatments were evaluated from days 2 to 5 of the first cycle after cisplatin administration among patients who had never before received chemotherapy. Methods. All patients were treated with chemotherapeutic regimens containing cisplatin greater than or equal to 80 mg/m 2 and received antiemetic therapy with granisetron 3 mg intravenously for the …

AdultMaleCancer ResearchMetoclopramideNauseamedicine.drug_classMetoclopramideVomitingmedicine.medical_treatmentAdministration OralGranisetronMethylprednisoloneGranisetronNeoplasmsmedicineAntiemeticHumansProspective StudiesAgedChemotherapybusiness.industryNauseaMiddle AgedOncologyMethylprednisoloneAnesthesiaVomitingCorticosteroidAntiemeticsDrug Therapy CombinationFemalemedicine.symptomCisplatinbusinessmedicine.drugCancer
researchProduct

Autoimmune hepatitis following Epstein-Barr virus infection

2008

We describe a case of a young man with autoimmune hepatitis (AIH) following Epstein–Barr virus (EBV) infection, in whom a long follow-up showed favourable outcome with complete clinical recovery and failure to relapse after cessation of immunosuppressive therapy. The study underlines the importance of the differential diagnosis between primary EBV associated hepatitis with features of autoimmunity, in which there is a direct pathogenetic role of the virus, and EBV related AIH, in which EBV could act as the trigger of the immune mediated damage with probable differences between the two conditions with regard to the prognosis and the responsiveness to immunosuppressive treatment. The favourab…

AdultMaleEpstein-Barr Virus InfectionsHepatitis Viral HumanAnti-Inflammatory AgentsAzathioprineDiseaseAutoimmune hepatitisSettore MED/08 - Anatomia Patologicamedicine.disease_causeMethylprednisoloneArticleVirusAutoimmunityDiagnosis Differentialimmune system diseaseshemic and lymphatic diseasesAzathioprinemedicineHumansEpstein–Barr virus infectionHepatitisbusiness.industryGeneral Medicinemedicine.diseasedigestive system diseasesHepatitis AutoimmuneLiverImmunologyDrug Therapy CombinationEBV autoimmune hepatitisDifferential diagnosisbusinessImmunosuppressive Agentsmedicine.drugCase Reports
researchProduct

Continuous intravenous infusion of dipyridamole as adjunctive therapy in the treatment of thrombotic thrombocytopenic purpura.

2003

Abstract Thrombotic thrombocytopenic purpura (TTP) is an uncommon hematologic thrombotic disorder characterized by fever, hemorrhagic and neurologic signs. The advent of plasma exchange has dramatically improved the prognosis of this disease, which was once inevitably fatal. However, mortality rates remain significant. Antiplatelet drugs have been widely used in combination with plasma exchange. In this pilot study we investigated the effects of an adjunctive therapy consisting of the continuous, intravenous infusion of dipyridamole, a modality of administration that has not been previously tested in this setting. Sixteen untreated TTP patients, diagnosed consecutively at our clinic, receiv…

AdultMaleTime FactorsCombination therapyThrombotic thrombocytopenic purpuraPilot ProjectsMethylprednisolonelaw.inventionRandomized controlled trialRefractorylawRecurrencemedicineHumansPlateletIn patientProspective StudiesInfusions IntravenousPlasma ExchangePurpura Thrombotic Thrombocytopenicbusiness.industryPlatelet CountMortality rateRemission InductionHematologyDipyridamoleMiddle Agedmedicine.diseaseCombined Modality TherapyDipyridamoleTreatment OutcomeAnesthesiaFemalebusinessPlatelet Aggregation Inhibitorsmedicine.drugTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
researchProduct

Effect of Corticosteroids on Facial Function after Cerebellopontine Angle Tumor Removal: A Double-Blind Study versus Placebo

2015

The aim of this study was to assess the effect of corticosteroids administered intra- and postoperatively on the occurrence of facial palsy after a cerebellopontine angle (CPA) tumor resection, and to investigate pre- and intraoperative prognostic factors. A multicenter, prospective, randomized, double-blind and versus-placebo study was conducted between 2006 and 2010. Three hundred and ten patients operated on for a CPA tumor (96% vestibular schwannomas, 4% miscellaneous) were included by five participating centers. The population was stratified into patients with small (≤15 mm CPA on axial MRI views) and large tumors. In each group, patients were randomized to receive corticosteroid (1 mg…

AdultMalemedicine.medical_specialtyAdolescentPhysiologymedicine.drug_classFacial ParalysisPopulationPlaceboMethylprednisoloneDouble blind studyYoung AdultSpeech and HearingPostoperative ComplicationsDouble-Blind MethodAdrenal Cortex HormonesmedicineHumanseducationGlucocorticoidsGrading (tumors)AgedAged 80 and overPostoperative Careeducation.field_of_studyIntraoperative CarePalsybusiness.industry[SCCO.NEUR]Cognitive science/NeuroscienceNeuroma AcousticMiddle AgedCerebellopontine anglemedicine.diseaseSensory SystemsFacial paralysisSurgeryOtorhinolaryngologyMethylprednisoloneCorticosteroidFemaleNeurology (clinical)Tumor removalbusinessmedicine.drug
researchProduct

Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observ…

2018

BACKGROUND: European guidelines recommend intravenous methylprednisolone as first-line treatment for active and severe Graves' orbitopathy; however, it is common for patients to have no response or have relapse after discontinuation of treatment. We aimed to compare the efficacy and safety of add-on mycophenolate to methylprednisolone in comparison with methylprednisolone alone in patients with moderate-to-severe Graves' orbitopathy.METHODS: MINGO was an observer-masked, multicentre, block-randomised, centre-stratified trial done in two centres in Germany and two in Italy. Patients with active moderate-to-severe Graves' orbitopathy were randomly assigned to receive intravenous methylprednis…

AdultMalemedicine.medical_specialtyCombination therapyAdolescentEndocrinology Diabetes and MetabolismPopulationMedizinAnti-Inflammatory Agents030209 endocrinology & metabolismMethylprednisoloneSeverity of Illness IndexMycophenolic acidlaw.inventionGraves' ophthalmopathy03 medical and health sciencesYoung Adult0302 clinical medicineEndocrinologyRandomized controlled trialDouble-Blind MethodlawInternal medicineJournal ArticleInternal MedicinemedicineHumanseducationAdverse effectAgededucation.field_of_studyAntibiotics Antineoplasticbusiness.industryMiddle AgedMycophenolic Acidmedicine.diseaseDiscontinuationGraves OphthalmopathyTreatment OutcomeMethylprednisoloneItaly030221 ophthalmology & optometryDrug Therapy CombinationFemalebusinessmedicine.drugThe lancet. Diabetesendocrinology
researchProduct

Immunosuppressive treatment in bilateral vestibulopathy with inner ear antibodies.

2005

Although vestibular recovery was observed after steroid treatment, it remains uncertain whether this improvement was spontaneous or due to medication. These data do not allow us to generally recommend corticosteroid treatment in patients with BVF and inner ear antibodies.A retrospective study was performed based on the observation of two patients with suspected autoimmune bilateral vestibular failure (BVF) with normal hearing and antilabyrinthine or nervous tissue-specific serum antibodies who showed vestibular recovery after corticosteroid treatment.Twelve patients with BVF and serum inner ear antibodies who had received imuunosuppressive treatment with corticosteroids were evaluated in te…

AdultMalemedicine.medical_specialtyFluorescent Antibody TechniqueEar diseaseMethylprednisoloneNystagmus PathologicAutoimmune Diseasesotorhinolaryngologic diseasesmedicineCaloric TestsAnimalsHumansMedical historyInner earGlucocorticoidsAgedAutoantibodiesRetrospective StudiesVestibular systemmedicine.diagnostic_testbusiness.industryElectronystagmographyAutoimmune inner ear diseaseGeneral MedicineReflex Vestibulo-OcularMiddle Agedmedicine.diseaseBilateral vestibulopathySurgeryRatsmedicine.anatomical_structureTreatment OutcomeOtorhinolaryngologyElectronystagmographyVestibular DiseasesAnesthesiaEar InnerImmunoglobulin GFemalesense organsVestibulo–ocular reflexbusinessFollow-Up StudiesActa oto-laryngologica
researchProduct

The in vitro addition of methotrexate and/or methylprednisolone determines peripheral reduction in Th17 and expansion of conventional Treg and of IL-…

2014

The aim of our study was to evaluate methotrexate (MTX) and methylprednisolone (MP) effect on peripheral Th17 and Treg subsets in patients with rheumatoid arthritis (RA). We enrolled 15 patients (10 early RA and 5 long-standing disease) with active RA and 10 age-matched healthy donors as controls. Frequencies of Th17 and Treg were quantified using flow cytometry before and after in vitro addition of MTX, MP or both drugs. Our results showed a reduction in the overall Th17 population followed by an increase in Th17 IL-10+ and Treg, after in vitro treatment of PBMCs with the drugs in patients with early RA. Long-standing disease patients showed a less evident increase in Treg cells and less e…

AdultMalemedicine.medical_specialtyImmunologyPopulationArthritischemical and pharmacologic phenomenaPeripheral blood mononuclear cellMethylprednisoloneT-Lymphocytes RegulatoryArthritis RheumatoidRheumatologyInternal medicinemedicineImmunology and AllergyHumanseducationRheumatoid arthritieducation.field_of_studybusiness.industryhemic and immune systemsMiddle Agedmedicine.diseaseRheumatologyInterleukin-10TregSettore MED/16 - ReumatologiaMethotrexateMethylprednisoloneRheumatoid arthritis Th17 TregRheumatoid arthritisAntirheumatic AgentsImmunologyTh17 CellsMethotrexateFemaleTh17Interleukin 17businessmedicine.drug
researchProduct

Antiinflammatory treatment and intestinal alpha 1-antitrypsin clearance in active Crohn's disease.

1985

Intestinal alpha 1-antitrypsin clearance was quantified in 17 patients with clinically active Crohn's disease before and after a six-week period of treatment with sulfasalazine and methylprednisolone. Before the study, alpha 1-antitrypsin clearance and, hence, enteric protein loss was elevated as being above control values in 16 patients. After therapy, clearance values decreased in 11 and were normalized in five patients. Serum albumin level was normalized in 11 of 12 patients who had hypoalbuminemia before the study. Clinical condition was improved in all but 1 patient after treatment. There was no close correlation between alpha 1-antitrypsin clearance and disease activity index. These r…

AdultMalemedicine.medical_specialtyPathologyAdolescentPhysiologyProtein-Losing EnteropathiesSerum albuminAnti-Inflammatory AgentsGastroenterologyMethylprednisoloneFecesCrohn DiseaseSulfasalazineInternal medicinemedicineHumansHypoalbuminemiaIntestinal MucosaSerum AlbuminCrohn's diseasebiologybusiness.industryProtein losing enteropathyGastroenterologyAlbuminHepatologyMiddle Agedmedicine.diseasedigestive system diseasesSulfasalazineMethylprednisolonealpha 1-Antitrypsinbiology.proteinFemalebusinessmedicine.drugDigestive diseases and sciences
researchProduct

Steroids in Acute Spinal Cord Injury: All But Gone Within 5 Years.

2019

Background Spinal cord injury (SCI) is a devastating event often leading to poor neurologic outcomes. One of the most widely practiced treatments has been the administration of methylprednisolone. However, today its use has been called into question over concerns of efficacy and safety. The present study evaluated the changes in the practice of steroid administration in acute SCI among members of the National Spinal Society in Poland in comparison with the results of the survey conducted in 2013. Methods The questionnaire, comprising 5 questions, was distributed among 240 spinal surgeons, members of the Polish Society of Spinal Surgery; of these, 97 (40%) responded. The results were compare…

AdultMalemedicine.medical_specialtyTime FactorsAnti-Inflammatory AgentsSpinal cord injuryMethylprednisolone03 medical and health sciences0302 clinical medicineAge groupsSurveys and QuestionnairesMedicineHumansSurveySpinal cord injurySpinal Cord Injuriesbusiness.industryMiddle Agedmedicine.diseaseSpinal surgeryCritical appraisalNeurosurgeonsMethylprednisoloneClinical evidence030220 oncology & carcinogenesisEmergency medicineAcute spinal cord injurySurgeryFemaleSteroidsNeurology (clinical)Polandbusiness030217 neurology & neurosurgerymedicine.drugWorld neurosurgery
researchProduct